Stem cell scandal reverberates in U.S.
By San Diego Union Tribune,
San Diego Union Tribune
| 12. 18. 2005
S. Korea controversy leads to calls for more oversight
As a South Korean scientist defends against mounting accusations that he falsified evidence in a breakthrough stem cell study, researchers in California said the controversy has caused significant damage to a promising and fledgling field.
Doubts about Hwang Woo-suk's claims that he cloned human cells to create embryonic stem cells have made scientists wonder whether the prospect might remain elusive for years. Researchers and doctors hope to use this process to genetically tailor stem cells for patients suffering from such diseases as Parkinson's, diabetes and multiple sclerosis.
"It's a black eye on the whole world of science," Richard Murphy, president of the Salk Institute in La Jolla, said. "Exciting areas of research are always competitive . . . but healthy competition never justifies sloppy research, cutting corners or dishonest behavior."
In California, where voters approved $3 billion to jump-start stem cell research, the South Korean controversy has led to renewed calls for more oversight of publicly funded science.
Meanwhile, San Diego biologists say the scandal shows why the United States needs...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...